Sarah Hackley

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

Pfizer (United States)(Current)

Toho University

Universidade Federal do Paraná

Toho University Ohashi Medical Center

Pfizer (United Kingdom)

Sarah Hackley is an author at Pfizer (United States) specializing in rheumatoid arthritis pharmacotherapy, rheumatoid arthritis therapy, and pharmacotherapy.

Publications per year

2019–2024

Publications

Randomised, double-blind, phase III study comparing the infliximab biosimilar, PF-06438179/GP1111, with reference infliximab: efficacy, safety and immunogenicity from week 30 to week 54

Rieke Alten, Bogdan Batko, Tomas Hala et al. · RMD Open · 2019 · 26 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension

Marius M. Hoeper, Ralf Ewert, Pavel Jansa et al. · Circulation · 2024 · 22 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Long-term Efficacy, Safety, and Immunogenicity of the Infliximab (IFX) Biosimilar, PF-06438179/GP1111, in Patients with Rheumatoid Arthritis After Switching from Reference IFX or Continuing Biosimilar Therapy: Week 54–78 Data From a Randomized, Double-Blind, Phase III Trial

Stanley Cohen, S. Radominski, Hideto Kameda et al. · BioDrugs · 2020 · 16 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

1–3 of 3